Can diabetes medicine help with sadness?
Repurposing glucagon-like peptide-1 (GLP-1) receptor agonists for the treatment of depression: A systematic review of preclinical, observational and clinical investigations.
Not medical advice. For informational purposes only. Always consult a healthcare professional. Terms
Surprising Findings
Strong antidepressant effects in animals but minimal proof in human trials
Usually, when 83% of animal studies show a strong effect, early human trials follow suit. Here, that pattern breaks down.
Practical Takeaways
If you're taking a GLP-1 RA for diabetes or obesity and notice improved mood, discuss it with your doctor — but don’t assume it’s a depression treatment.
Not medical advice. For informational purposes only. Always consult a healthcare professional. Terms
Surprising Findings
Strong antidepressant effects in animals but minimal proof in human trials
Usually, when 83% of animal studies show a strong effect, early human trials follow suit. Here, that pattern breaks down.
Practical Takeaways
If you're taking a GLP-1 RA for diabetes or obesity and notice improved mood, discuss it with your doctor — but don’t assume it’s a depression treatment.
Publication
Journal
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology
Year
2025
Authors
Sophie Li, S. G. Sabbah, A. Kwan, R. McIntyre
Related Content
Claims (4)
People with type 2 diabetes or obesity who take GLP-1 drugs like semaglutide might be less likely to develop depression or anxiety.
So far, only one in three studies has found that diabetes drugs called GLP-1 agonists might help with depression, so the proof isn't strong or clear yet.
Some diabetes drugs called GLP-1 RAs might help with depression in animals — most lab studies saw fewer signs of depression, and scientists think it’s because these drugs change brain inflammation, brain cell connections, and brain chemicals.
Some diabetes drugs called GLP-1 agonists might help with depression symptoms, based on a few studies — but the results aren't clear-cut and more research is needed.